Pessary Market – By Type, By Application, By End Use – Global Forecast, 2025 – 2034

Key players in the market include Artisan Medical, Bioteque America, Bliss GVS Pharma, Bray Group (Ethos Partners), Coloplast Group, Contiform International, CooperSurgical, Dr. Arabin, Integra Lifesciences, MedGyn Products, Novomed group (Gyneas), Panpac Medical, and Personal Medical.

The U.S. pessary market generated approximately USD 169.7 million in 2024, driven by the high prevalence of pelvic disorders and the demand for non-invasive treatment options for women.

The global pessary industry was valued at USD 447.5 million in 2024 and is projected to grow at a 4.8% CAGR from 2025 to 2034, driven by the increasing prevalence of pelvic organ prolapse and urinary incontinence.

The ring pessary segment held a 51.6% market share in 2024 due to its broad applicability for treating mild to moderate prolapse and stress urinary incontinence, making it suitable for a wide patient population.